Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for male hypogonadism are effective and should be personalized.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

Thyroid problems can cause hair loss and change hair texture.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Activating TRPV3 stops human hair growth.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Parathyroid hormone-related protein helps control hair growth phases in mice.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Alopecia patients have less GPER-1, which might affect hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Growth factors are crucial for hair development and could help treat hair diseases.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

SHBG may be a useful early indicator and treatment target for PCOS.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Early diagnosis and treatment of TPP can prevent complications.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.